关节疼痛注射市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00003536
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 162
Buy Now

[研究报告]关节止痛注射剂市场规模预计将从2020年的36.6745亿美元增至2028年的69.9688亿美元;预计 2021 年至 2028 年复合年增长率为 8.5%。

关节疼痛注射可以更快地缓解剧烈疼痛并减少关节炎症。市场上有几种类型的注射剂,包括皮质类固醇注射剂、透明质酸(HA)注射剂、富血小板血浆(PRP)注射剂和胎盘组织基质(PTM)注射剂。关节疼痛注射市场的增长归因于肌肉骨骼疾病的高患病率和运动损伤数量的增加等因素。然而,关节修复疗法的高成本阻碍了市场增长

关节止痛注射市场的利润丰厚的地区


市场洞察


肌肉骨骼疾病的高患病率

肌肉骨骼疾病是影响颈部、肩部肌肉、骨骼和关节的医疗状况、手腕、背部、臀部、腿、膝盖和脚。这些疾病包括肌腱炎、腕管综合征、骨关节炎、类风湿性关节炎(RA)、纤维肌痛和骨折。根据世界卫生组织 (WHO) 2018 年更新的情况说明书,肌肉骨骼疾病是全球第二大致残因素。同样,随着全球人口老龄化的增加和非传染性疾病(NCD)危险因素患病率的上升,肌肉骨骼疾病的患病率和影响预计也会上升。根据 2016 年美国骨科医师学会的报告:年会数据显示,美国约有二分之一的成年人患有肌肉骨骼疾病。此外,根据美国疾病控制与预防中心 (CDC) 的数据,关节炎会导致严重疼痛,每年影响数百万人。大约四分之一的关节炎患者(即总计约 5400 万患者中的约 1500 万)经历过与关节炎相关的严重关节疼痛。

此外,骨关节炎 (OA) 是最常见的关节炎之一。美国最常见的关节疾病,由骨头之间的关节软骨破裂引起。它也被称为退行性关节疾病或“磨损”。关节炎。根据疾病控制与预防中心 (CDC) 的数据,美国有超过 3250 万成年人患有骨关节炎。同样,根据英国国家医疗服务体系 (NHS) 的数据,英国有超过 1000 万人患有关节炎或其他影响关节的类似疾病。根据 Bupa 健康保险,骨关节炎是英国最常见的关节炎形式,影响该国大约三分之一的 45 岁或以上的人口,即约 875 万人。因此,不同国家肌肉骨骼疾病的高患病率正在增加针对该疾病进行的治疗程序的数量,从而推动关节疼痛注射市场的增长。

基于药物的见解

关节止痛注射剂市场按药物细分为透明质酸、皮质类固醇等。皮质类固醇细分市场在 2020 年占据最大的市场份额,预计在预测期内复合年增长率最高。

关节疼痛注射市场,由毒品&nd; 2020年和2028年


基于关节类型的洞察

基于关节类型,关节疼痛注射市场分为膝盖、足踝、肩肘、臀部等应用。膝关节细分市场在 2020 年占据最大的市场份额,预计在预测期内将实现最高的复合年增长率。

基于分销渠道的洞察

基于分销渠道,关节止痛注射剂市场分为零售药店、医院药房等。伤口护理细分市场在 2020 年占据最大的市场份额,预计骨移植细分市场在预测期内的复合年增长率最高。

战略洞察

产品发布和批准是公司扩大全球足迹和产品组合的常用策略。此外,关节痛注射剂市场参与者注重合作策略来扩大客户群,这反过来又使他们能够在全球范围内保持自己的品牌声誉。

关节痛注射剂市场——按药物

  • 透明质酸
  • 皮质类固醇
  • 其他

关节痛注射市场按关节类型

  • 膝盖
  • 足和踝
  • 肩和肘
  • 其他

关节止痛注射市场 –按分销渠道划分

  • 零售药房
  • 医院药房
  • 其他

关节止痛注射剂市场按地理位置

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • < li>欧洲
    • 法国
    • 德国
    • 意大利
    • 英国
    • 西班牙
    • 休息欧洲
  • 亚太地区 (APAC)
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚
    • 亚太地区其他地区
  • 中东和非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南部和非洲中美洲 (SCAM)
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区
< p> 

公司简介

  • 中外制药株式会社            
  • Bioventus Inc.       
  • Fidia Pharma USA Inc.       
  • Flexion Therapeutics, Inc.           
  • 生化学株式会社         
  • Ferring BV          
  • 赛诺菲         
  • Anika Therapeutics 公司。            
  • 梯瓦制药        
  • OrthogenRx 公司
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are joint pain injections?

Joint pain injections are medicinal fluids inserted in the patient’s body to get faster relief from severe pain. The joint pain injections are used to reduce inflammation in the joints. There are several types of injections available in the market which are corticosteroids injections, hyaluronic acid (HA) injections, platelet-rich plasma (PRP) injections and placental tissue matrix (PTM) injections.

What are the driving factors for the joint pain injection market across the globe?

The global joint pain injection market growth is mainly attributed to factors such the high prevalence of musculoskeletal disorders and increasing number of sports injuries. However, the high costs of joint repair therapies hinder the market growth.

Who are the major players in the joint pain injection market?

The joint pain injection market majorly consists of the players such as Chugai Pharmaceutical Co., Ltd., Teva Pharmaceuticals, Bioventus Inc., Fidia Pharma USA Inc., Flexion Therapeutics, Inc., SEIKAGAKU CORPORATION, Ferring B.V., Sanofi, Anika Therapeutics, Inc., and OrthogenRx among others.

The List of Companies - Joint Pain Injection Market

  1. Chugai Pharmaceutical Co., Ltd.              
  2. Bioventus Inc.                
  3. Fidia Pharma USA Inc.                
  4. Flexion Therapeutics, Inc.          
  5. SEIKAGAKU CORPORATION       
  6. Ferring B.V.     
  7. Sanofi              
  8. Anika Therapeutics, Inc.             
  9. Teva Pharmaceutical                  
  10. OrthogenRx, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports